209 related articles for article (PubMed ID: 16343992)
1. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
Cheng YJ; Zhou Q; Li ZG
Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
4. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
5. [The study of inhibitory peptides on T cell activation in rheumatoid arthritis].
Li X; Li R; Zhang CH; Li ZG
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(24):1679-82. PubMed ID: 16251070
[TBL] [Abstract][Full Text] [Related]
6. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
8. [Proliferation of type II collagen specific T cell response and antibody formation in rheumatoid arthritis and their relations to HLA-DR4].
Zhou Q; Li X; Li R; Zheng WY; Li ZG
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):370-3. PubMed ID: 15854524
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus haemagglutinin-derived peptides inhibit T-cell activation induced by HLA-DR4/1 specific peptides in rheumatoid arthritis.
Li X; Li R; Li Z
Clin Exp Rheumatol; 2006; 24(2):148-54. PubMed ID: 16762149
[TBL] [Abstract][Full Text] [Related]
10. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection of DNA synthesis, activation and cytokine secretion in collagen II (250-270)-activated T lymphocytes by flow cytometry.
Zhu P; Li X; Ding J; Fan C; Wang Y; Wang H; Chen Z
Cell Biol Int; 2004; 28(11):765-72. PubMed ID: 15563398
[TBL] [Abstract][Full Text] [Related]
12. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
14. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis.
Kim HY; Kim WU; Cho ML; Lee SK; Youn J; Kim SI; Yoo WH; Park JH; Min JK; Lee SH; Park SH; Cho CS
Arthritis Rheum; 1999 Oct; 42(10):2085-93. PubMed ID: 10524679
[TBL] [Abstract][Full Text] [Related]
15. T cell epitopes of type II collagen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis.
Ohnishi Y; Tsutsumi A; Sakamaki T; Sumida T
Int J Mol Med; 2003 Mar; 11(3):331-5. PubMed ID: 12579335
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
[TBL] [Abstract][Full Text] [Related]
17. Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients.
Ohnishi Y; Tsutsumi A; Matsumoto I; Goto D; Ito S; Kuwana M; Uemura Y; Nishimura Y; Sumida T
Mod Rheumatol; 2006; 16(4):226-8. PubMed ID: 16906372
[TBL] [Abstract][Full Text] [Related]
18. Altered collagen II 263-272 peptide immunization induces inhibition of collagen-induced arthritis through a shift toward Th2-type response.
Li R; Li X; Li Z
Tissue Antigens; 2009 Apr; 73(4):341-7. PubMed ID: 19317744
[TBL] [Abstract][Full Text] [Related]
19. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
[TBL] [Abstract][Full Text] [Related]
20. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
Bäcklund J; Carlsen S; Höger T; Holm B; Fugger L; Kihlberg J; Burkhardt H; Holmdahl R
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9960-5. PubMed ID: 12089323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
